Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 700 participants.
Also called NCT00673842
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 700 participants
- Sponsor
- Registry
-
NCT00673842
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Belgium, Canada, Finland, France, Germany, Hungary, Italy, Norway, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT00673842. Randomized; no masking; primary purpose treatment. Start 2011-04-18 (actual); primary completion 2024-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
- Acronym
- REFINE-ICD
- Condition
- Myocardial Infarction
- Condition
- Sudden Death
- Intervention (Device)
- Implantable Cardioverter Defibrillator + Usual Care
- Intervention (Other)
- Usual care
- Lead sponsor
- University of Calgary
- Collaborator
- Canadian Institutes of Health Research (CIHR)
- Collaborator
- Alberta Innovation and Science
- Collaborator
- Medtronic
- Collaborator
- GE Healthcare
- Collaborator
- Cardiac Arrhythmia Network of Canada
- Collaborator
- Accelerating Clinical Trials Consortium
Record details
- Record id
cardio:ct-nct00673842- Content hash
9dd8735b15f2a3feb2a1c6b798a107f3aa4ea7f7ced21c86a6f7f7827e736493